Lara Gharibeh, PhD (@laragharibeh) 's Twitter Profile
Lara Gharibeh, PhD

@laragharibeh

Principal Scientific Affairs Specialist | Boston Scientific | Structural Heart | Cardiology | Travel & Photography Enthusiast | 🇱🇧🇨🇦

ID: 864625482016460800

calendar_today16-05-2017 23:35:53

1,1K Tweet

670 Followers

723 Following

Lara Gharibeh, PhD (@laragharibeh) 's Twitter Profile Photo

➡️ Decided recently to make a career change Excited to announce that I have accepted a new position as Senior Scientific Affairs Associate at Boston Scientific/Baylis Medical🎉 Happy to embark on this new adventure, helping Boston Scientific grow their organization within the🫀area #newjob

➡️ Decided recently to make a career change

Excited to announce that I have accepted a new position as Senior Scientific Affairs Associate at <a href="/bostonsci/">Boston Scientific</a>/<a href="/BaylisMedical/">Baylis Medical</a>🎉

Happy to embark on this new adventure, helping <a href="/bostonsci/">Boston Scientific</a> grow their organization within the🫀area #newjob
Giovanni Ferrari PhD (@ferrag02) 's Twitter Profile Photo

Two "Churro Awards" this month to celebrate @EstiCastillero 's Science Translational Medicine and Yingfei Xue / Alexey Abramov, MD MS 's PNAS ? Impressive, most impressive FerrariLab @Columbia ! our Chief Vision Office is really proud 🐶🐕‍🦺🧪🧬🫀

Two "Churro Awards" this month to celebrate @EstiCastillero 's Science Translational Medicine and <a href="/Phil_Xue/">Yingfei Xue</a> / <a href="/aabramov_md/">Alexey Abramov, MD MS</a> 's PNAS ? Impressive, most impressive <a href="/lab_ferrari/">FerrariLab @Columbia</a> ! our Chief Vision Office is really proud 🐶🐕‍🦺🧪🧬🫀
Boston Scientific (@bostonsci) 's Twitter Profile Photo

BSX announces Q4 and Full Year 2022 financial results. Refer to our release for more information & non-GAAP reconciliations: bit.ly/3wJoROv

BSX announces Q4 and Full Year 2022 financial results. Refer to our release for more information &amp; non-GAAP reconciliations: bit.ly/3wJoROv
Lara Gharibeh, PhD (@laragharibeh) 's Twitter Profile Photo

International Women’s Day allows us to reflect on our progress, set new goals, and #EmbraceEquity. Thank you Boston Scientific BostonSci Cardiology Boston Scientific EMEA - Cardiology for everything you do to support women’s advancement in the workplace and beyond. #IWD23 Here’s to strong women! #IWD23

International Women’s Day allows us to reflect on our progress, set new goals, and #EmbraceEquity. 

Thank you <a href="/bostonsci/">Boston Scientific</a> <a href="/BSCCardiology/">BostonSci Cardiology</a> <a href="/BSC_EU_Heart/">Boston Scientific EMEA - Cardiology</a> for everything you do to support women’s advancement in the workplace and beyond. #IWD23 

Here’s to strong women! #IWD23
BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

Late breaking clinical trial results from the SURPASS 1-Year analysis presented at #CRT2023 continue to highlight the industry-leading safety profile of the WATCHMAN FLX™ #LAAC Implant observed in separate controlled & real-world studies. View the data: bit.ly/3ZRijtG

Late breaking clinical trial results from the SURPASS 1-Year analysis presented at #CRT2023 continue to highlight the industry-leading safety profile of the WATCHMAN FLX™ #LAAC Implant observed in separate controlled &amp; real-world studies.

View the data: bit.ly/3ZRijtG
Boston Scientific EMEA - Cardiology (@bsc_eu_heart) 's Twitter Profile Photo

We're excited to announce Boston Scientific has obtained CE Mark for POLARx™ FIT cryoballoon catheter, the only cryoablation system offering dual diameter balloon size in one catheter to give an individualised fit for greater procedural flexibility, despite variable anatomies

We're excited to announce Boston Scientific has obtained CE Mark for POLARx™ FIT cryoballoon catheter, the only cryoablation system offering dual diameter balloon size in one catheter to give an individualised fit for greater procedural flexibility, despite variable anatomies
Boston Scientific EMEA - Cardiology (@bsc_eu_heart) 's Twitter Profile Photo

We're looking forward to meet the #healthcare community tomorrow at #EHRA2023. Visit us at booth E100 to learn from leaders in #electrophysiology about the latest clinical data and our innovative technologies. Discover more: bit.ly/40cNsYj #BSCEMEA

We're looking forward to meet the #healthcare community tomorrow at #EHRA2023. Visit us at booth E100 to learn from leaders in #electrophysiology about the latest clinical data and our innovative technologies. 
Discover more: bit.ly/40cNsYj
#BSCEMEA
Giovanni Ferrari PhD (@ferrag02) 's Twitter Profile Photo

New publication: on #Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic #AorticAneurysm ⁦Hiroo Takayama⁩ ⁦FerrariLab @Columbia⁩ ⁦Valley Health System⁩ ⁦Columbia Surgery⁩ ⁦Dov Levine⁩ imrpress.com/journal/RCM/24…

Reviews in Cardiovascular Medicine (@rcmjournal) 's Twitter Profile Photo

#RCM - Vol. 24 No. 6 🏆Review Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm 📍from Lara Gharibeh, PhD, @EstiCastillero, Giovanni Ferrari PhD, Hiroo Takayama, Juan B. Grau et al. #BAV #TAA 🔓 imrpress.com/journal/RCM/24…

#RCM - Vol. 24 No. 6
🏆Review
Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm
📍from <a href="/LaraGharibeh/">Lara Gharibeh, PhD</a>, @EstiCastillero, <a href="/ferrag02/">Giovanni Ferrari PhD</a>, <a href="/HirooTakayamaMD/">Hiroo Takayama</a>, Juan B. Grau et al.

#BAV #TAA
🔓
imrpress.com/journal/RCM/24…
BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

POLARx™ FIT #cryoablation balloon catheter is now FDA approved. Introducing the only catheter with two balloon sizes for paroxysmal #AFib. Designed to improve occlusion and ablation confidence. bit.ly/4502IuK Safety info: bit.ly/3KyDJGu

POLARx™ FIT #cryoablation balloon catheter is now FDA approved. Introducing the only catheter with two balloon sizes for paroxysmal #AFib. Designed to improve occlusion and ablation confidence. bit.ly/4502IuK

Safety info: bit.ly/3KyDJGu
BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo).

BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

Congrats to Dr. Wilber Su and team at Banner Health for completing the first US commercial case using the POLARx™ FIT #cryoablation System! This is an important milestone for the treatment of patients with paroxysmal #afib. Safety info: bit.ly/3qh50GJ

Congrats to Dr. <a href="/su_wilber/">Wilber Su</a> and team at <a href="/BannerHealth/">Banner Health</a>  for completing the first US commercial case using the POLARx™ FIT #cryoablation System! This is an important milestone for the treatment of patients with paroxysmal #afib.

Safety info: bit.ly/3qh50GJ
BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

Secure effortless delivery for cryo procedures: The VersaCross™ Large Access Solution features a seamless design for reliably smoother advancement of large therapy sheaths at the femoral vein & the septum. Learn more: bit.ly/3L51QNl #EPeeps IFU: bit.ly/45ybGzw

BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

Improved M-TEER procedural efficiency: In a recent study, operators reduced the number of wires & exchanges required using an RF wire-based workflow, in comparison to a standard needle-based workflow. Learn more: bit.ly/3Epllg2 IFU: bit.ly/3EqyTro

BostonSci Cardiology (@bsccardiology) 's Twitter Profile Photo

POLARx™ FIT is a unique #cryoablation catheter allowing for 28mm and 31mm cryoballoon expansion for the treatment of paroxysmal #AFib. Learn more about the POLARx™ FIT difference: bit.ly/3rirR59 Safety info: bit.ly/3PmcIrv

Boston Scientific (@bostonsci) 's Twitter Profile Photo

Further expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension. bit.ly/3XoenBP

Further expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension. bit.ly/3XoenBP